• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

_|Coordinated evolution of the hepatitis C virus|_

Giuseppe

Emeritus
Coordinated evolution of the hepatitis C virus
D. S. Campo*,?, Z. Dimitrova*, R. J. Mitchell?, J. Lara*, and Y. Khudyakov*,?
+Author Affiliations
*Molecular Epidemiology and Bioinformatics Laboratory, Division of Viral Hepatitis, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333; and ?Department of Genetics and Human Variation, School of Molecular Sciences, La Trobe University, Bundoora, Victoria 3086, Australia
Edited by Francisco J. Ayala, University of California, Irvine, CA, and approved April 23, 2008 (received for review February 22, 2008)

Abstract
Hepatitis C virus is a genetically heterogeneous RNA virus that is a major cause of liver disease worldwide.

Here, we show that, despite its extensive heterogeneity, the evolution of hepatitis C virus is primarily shaped by negative selection and that numerous coordinated substitutions in the polyprotein can be organized into a scale-free network whose degree of connections between sites follows a power-law distribution.

This network shares all major properties with many complex biological and technological networks.

The topological structure and hierarchical organization of this network suggest that a small number of amino acid sites exert extensive impact on hepatitis C virus evolution.

Nonstructural proteins are enriched for negatively selected sites of high centrality, whereas structural proteins are enriched for positively selected sites located in the periphery of the network.

The complex network of coordinated substitutions is an emergent property of genetic systems with implications for evolution, vaccine research, and drug development.

In addition to such properties as polymorphism or strength of selection, the epistatic connectivity mapped in the network is important for typing individual sites, proteins, or entire genetic systems.

The network topology may help devise molecular intervention strategies for disrupting viral functions or impeding compensatory changes for vaccine escape or drug resistance mutations.

Also, it may be used to find new therapeutic targets, as suggested in this study for the NS4A protein, which plays an important role in the network.

complex systems scale-free network covariation natural selection epistasis
Footnotes
?To whom correspondence may be addressed. E-mail: fyv6@cdc.gov or yek0@cdc.gov Author contributions: D.S.C., R.J.M., and Y.K. designed research; D.S.C. and Z.D. performed research; D.S.C., Z.D., and J.L. analyzed data; and D.S.C. and Y.K. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
This article contains supporting information online at

http://www.pnas.org/content/105/28/9685.short
-----
 
Back
Top Bottom